Medical News

RSS

Worry over unmanned ambulances: Plans for extra manpower at Geelong call center for emergency calls

According to a recent statement of the paramedic’s union, Moe’s ambulances are often unmanned putting the lives of all the residents at risk.

16 Apr 2010

Investigations and attempts to fix the major QH staff pay bungle

After the recent mistake in payment of the Queensland Health staff much has been debated. In this huge error nearly 3000 people working for QH have been left un-paid or underpaid.

16 Apr 2010

Trans-urethral prostate hyperthermia treatment offers 100% response rate

According the Dr. Friedrich Douwes, Medical Director of St. George Hospital in Bad Aibling, Germany, president of the German Oncological Society and the author of several hundred scientific articles and books, trans-urethral prostate hyperthermia has a 100% initial response rate.

16 Apr 2010

UALR researcher receives federal grant to track estrogen-mimicking compounds in consumer products

Dr. Jerry Darsey, professor of chemistry in UALR's College of Science and Mathematics, has received $77,000 from a federal Food and Drug Administration grant to develop methods to track estrogen mimicking compounds in various products and assess how use of the products affect women.

16 Apr 2010

New research identifies cellular channel that regulates skin and hair growth

Skin and hair follicles are constantly renewed in the body, maintained by specialized stem cells. New research from Children's Hospital Boston identifies a small cellular channel that regulates skin and hair growth and that could be targeted with small-molecule drugs, potentially treating variety of skin conditions, as well as thinning hair or unwanted hair growth. Findings appear in the April 16, 2010 issue of Cell.

16 Apr 2010

IFT offers support for President's Task Force on Childhood Obesity

In comments delivered to the Obama Administration, the Institute of Food Technologists today offered its support for the President's Task Force on Childhood Obesity and efforts by First Lady Michelle Obama designed to raise awareness on the critical issue of childhood obesity.

16 Apr 2010

PPA helps qualified patients save money on their medicines

As recently noted in the Queens Chronicle, a nationwide partnership, consisting of more than 475 public and private assistance programs, is helping qualified patients save money on their medicines.

16 Apr 2010

LOTS results of Myozyme in older children and adults with Pompe disease published

Genzyme Corp. today announced that the results from its Late-Onset Treatment Study have been published in today's New England Journal of Medicine. The study was undertaken to evaluate the safety and efficacy of Myozyme (alglucosidase alfa) in older children and adults with Pompe disease.

16 Apr 2010

Novartis Pharma AG initiates second Phase I trial for oral PTH1-34: Emisphere Technologies

Emisphere Technologies, Inc. today announced that Novartis Pharma AG has initiated a second Phase I trial for an oral PTH1-34 which uses Emisphere's Eligen Technology, and is in development for the treatment of postmenopausal osteoporosis. Emisphere Technologies is a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen Technology.

16 Apr 2010

IBA's PBS system for Proton Therapy granted CE Mark

IBA's second generation Pencil Beam Scanning system for Proton Therapy, which further enhances the performance of anti-cancer proton treatments, has been granted the CE Mark, certifying that the product has met European Union medical device regulations.

16 Apr 2010

Drugstores try to increase their presence with in-store clinic market

Drugstores are trying to bolster their presence in the in-store clinic market, even though the concept has thus far not been a particularly profitable one.

16 Apr 2010

Moving is the best medicine for arthritic pain

The burden of arthritis is greater for African Americans and Hispanics, despite lower prevalence among these groups according to a Centers for Disease Control and Prevention (CDC) report published in the May issue of Preventing Chronic Disease.

16 Apr 2010

Boston Scientific receives FDA clearance to resume distribution of COGNIS CRT-Ds and TELIGEN ICDs

Boston Scientific Corporation today announced that it has received U.S. Food and Drug Administration clearance for the two validated manufacturing changes affecting all of its cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators, and that it will immediately resume distribution of its COGNIS CRT-Ds and TELIGEN ICDs.

16 Apr 2010

New scale more suitable for predicting depressive symptoms

A research team has tested the utility of the short version of WHO-DAS II, a tool to assess within five minutes disability in patients with depression, "which in the case of primary care is even more practicable than the long version of the instrument." In Spain, more than 10% of the population suffer from severe depression.

16 Apr 2010

Mass. insurers to revise rates or face fines; In Conn., a lawmaker hopes to help with insurance denials

"State regulators [Tuesday] demanded that health insurers submit revised April 1 premium rates for tens of thousands of individuals and small businesses by 3 p.m. [Thursday] or face stiff fines," The Boston Globe reports.

16 Apr 2010

Low income and lack of health insurance result in fewer rate of colorectal cancer screening

High out-of-pocket costs, lack of health insurance and limited access to care contribute to a relatively low rate of colorectal cancer screening in the United States, according to a new systematic review by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center.

16 Apr 2010

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.

16 Apr 2010

NPS Pharmaceuticals proposes underwritten public offering of common stock

NPS Pharmaceuticals, Inc. today announced that it intends to offer, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering. In connection with this offering, the Company expects to grant to the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock to cover overallotments, if any.

16 Apr 2010

Nottingham and Japanese scientists to study genetic variation of E. coli bacteria

University of Nottingham scientists will join forces with Japan in the fight against a common bacterium - thanks to an international research award.

16 Apr 2010

Certain genetic variations linked to tooth decay, periodontitis

Certain genetic variations may be linked to higher rates of tooth decay and aggressive periodontitis, according to two recently published papers by researchers at the University of Pittsburgh School of Dental Medicine and their collaborators.

16 Apr 2010

Medical News

Worry over unmanned ambulances: Plans for extra manpower at Geelong call center for emergency calls

Investigations and attempts to fix the major QH staff pay bungle

Trans-urethral prostate hyperthermia treatment offers 100% response rate

UALR researcher receives federal grant to track estrogen-mimicking compounds in consumer products

New research identifies cellular channel that regulates skin and hair growth

IFT offers support for President's Task Force on Childhood Obesity

PPA helps qualified patients save money on their medicines

LOTS results of Myozyme in older children and adults with Pompe disease published

Novartis Pharma AG initiates second Phase I trial for oral PTH1-34: Emisphere Technologies

IBA's PBS system for Proton Therapy granted CE Mark

Drugstores try to increase their presence with in-store clinic market

Moving is the best medicine for arthritic pain

Boston Scientific receives FDA clearance to resume distribution of COGNIS CRT-Ds and TELIGEN ICDs

New scale more suitable for predicting depressive symptoms

Mass. insurers to revise rates or face fines; In Conn., a lawmaker hopes to help with insurance denials

Low income and lack of health insurance result in fewer rate of colorectal cancer screening

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

NPS Pharmaceuticals proposes underwritten public offering of common stock

Nottingham and Japanese scientists to study genetic variation of E. coli bacteria

Certain genetic variations linked to tooth decay, periodontitis

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News